Home / Stocks / STOK

STOK insider trading

Stoke Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-12Krainer Adrian R.
Director
Sold33,243$39.74$1.3M
2025-11-26Krainer Adrian R.
Director
Sold40,472$29.72$1.2M
2025-10-07Kaye Edward M. MD
Director
Sold42,461$25.09$1.1M
2025-06-06Blue Horizon Enterprise Ltd
10% owner
Sold3,000,000$10.20$30.6M
2024-12-27Blue Horizon Enterprise Ltd
10% owner
Sold2,000,000$11.50$23.0M
2024-09-23Blue Horizon Enterprise Ltd
10% owner
Sold1,937,500$14.05$27.2M

See STOK on the chart

Every insider buy and sell for STOK plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.